Source: Annual Congress 2010 - Lung morbidity on exposure to various agents
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. de Torres, D. Blanco, A. Munoz-Barrutia, C. Ortiz-de-Solorzano, L. Montuenga, G. Bastarrika, D. Perez-Martin, M. Ceresa, G. de Biurrun, U. Montes, J. Zulueta (Pamplona, Spain). Airway obstruction and or emphysema shows a different plasma inflammatory response in asymptomatic smokers or ex-smokers participating in a lung cancer screening program. Eur Respir J 2010; 36: Suppl. 54, 4468

Member's Comments

No comment yet.

Related content which might interest you: Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers Source: Eur Respir J 2005; 26: 835-845 Year: 2005 Small airway function in smokers without airway obstruction Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Airway epithelial cell apoptosis and inflammation in COPD, smokers and nonsmokers Source: Eur Respir J 2013; 41: 1058-1067 Year: 2013 Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis Source: Eur Respir J 2007; 30: 467-471 Year: 2007 Cell spectrum and oxidant/anti-oxidant status of induced sputum in smokers with airway obstruction versus smokers without obstruction and nonsmokers Source: Eur Respir J 2001; 18: Suppl. 33, 92s Year: 2001 Airway and systemic inflammation profile in current smokers controls, COPD current smokers and COPD ex-smokers Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Enhanced T cell growth from bronchial biopsies of COPD ex-smokers and severe asthmatic subjects compared to COPD current smokers Source: Eur Respir J 2004; 24: Suppl. 48, 39s Year: 2004 Airway inflammatory cell compounds in smokers and ex-smokers with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 798s Year: 2006 Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Small airway function and peripheral airway disease in healthy subjects and smokers Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 Analysis of the mucus properties in smokers with lung cancer or extra-pulmonary cancer and non smokers with pulmonary metastasis Source: Eur Respir J 2006; 28: Suppl. 50, 656s Year: 2006 Is lung emphysema in COPD patients reflected by central airways inflammation? Source: Eur Respir J 2003; 22: Suppl. 45, 207s Year: 2003 Angiogenesis in bronchial biopsies of symptomatic smokers with and without lung cancer Source: Annual Congress 2008 - Basic science in asthma and COPD II Year: 2008 COPD and lung cancer incidence in never smokers Source: International Congress 2019 – Asthma and COPD comorbidities Year: 2019 Airways and systemic inflammation and correlation to lung function in smokers and in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 651s Year: 2006 Smoking and airway inflammation in asymptomatic subjects and in patients with chronic airway disease Source: Eur Respir J 2002; 20: Suppl. 38, 90s Year: 2002 Distal airway dysfunction identifies pulmonary inflammation in asymptomatic smokers Source: ERJ Open Res, 2 (4) 00066-2016; 10.1183/23120541.00066-2016 Year: 2016 Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009 Airway pathology in COPD compared to that in smokers with asthma Source: Annual Congress 2008 - Smokers with asthma versus COPD: differences and similarities Year: 2008 Inflammation of airways and results of 6-MWT at smokers with bronchial asthma. Source: International Congress 2017 – Smoking and molecular findings Year: 2017